Profile
ABOS VRTX REGN VRNA ALNY ARGX
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $122.36M $124.24B $78.83B $72.68B $55.82B $50.34B
Employees 0.06K 6.10K 15.16K 0.21K 2.23K 1.60K
CEO Daniel J. O'Connell Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Yvonne L. Greenstreet Timothy Van Hauwermeiren
Ratings
ABOS VRTX REGN VRNA ALNY ARGX
Quant Rating Score 2 4 4 1 3 4
Quant Rating Sell Buy Buy Strong Sell Neutral Buy
Trading
ABOS VRTX REGN VRNA ALNY ARGX
Last Close $1.58 $434.02 $704.31 $106.91 $460.54 $929.61
High 52 $2.39 $513.76 $788 $106.91 $491.09 $929.61
Low 52 $0.9 $366.54 $482.92 $37.86 $224.58 $532.27
Price vs. 52 Week High -33.89 % -15.52 % -10.62 % 0 % -6.22 % 0 %
Price vs. 52 Week Low 75.56 % 18.41 % 45.84 % 182.38 % 105.07 % 74.65 %
Total Return
ABOS VRTX REGN VRNA ALNY ARGX
1 Month Return -22.17 % 4.13 % 21.84 % 0 % -4.39 % 10.19 %
3 Month Return 10.49 % 11.32 % 22.74 % 1.06 % 0.8 % 40.57 %
6 Month Return 47.66 % -1.06 % 18.51 % 49.92 % 61.42 % 64.35 %
9 Month Return 9.34 % -6.08 % 3.57 % 66.4 % 84.22 % 45.48 %
YTD Return -8.14 % 7.78 % -1.13 % 130.21 % 95.72 % 51.16 %
1 Year Return -33.89 % -3.12 % -5.41 % 180.68 % 96.59 % 61.8 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX REGN VRNA ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.46 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1405.19 % 9.76 % 4.25 % -147.93 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
ABOS VRTX REGN VRNA ALNY ARGX
Asset Growth -22.94 % 14.15 % 36.55 %
Gross Profit Growth 99.58 % 12.5 % 77.08 %
Revenue Growth - 8.27 % 78.6 %
Revenue 3 Year - -13.44 % 275.84 %
Revenue 5 Year -100 % 119.18 % 1701.04 %
Revenue 10 Year -100 % 429.43 % 12483.14 %
EBIT Growth -89.73 % 13.17 % 128.87 %
Net Income Growth -95.39 % 11.61 % 382.34 %
Net Income 3 Yeari Growth Per Share 35.14 % -46.47 % 274.39 %
Net Income 5 Yeari Growth Per Share -517.86 % 111.07 % 396.61 %
Net Income 10 Yeari Growth Per Share -517.86 % 1232.49 % 1842.73 %
Operating Income Growth -86.49 % -8.23 % 94.91 %
Operating Cash Flow Growth (CFG) -100.2 % -3.78 % 80.31 %
Operating 3 Year CFG -206.07 % -38.85 % 88.36 %
Operating 5 Year CFG -503.71 % 84.11 % -135.21 %
Operating 10 Year CFG -503.71 % 517.51 % -241.05 %
EPS Growth -58.33 % 10.39 % 369.77 %
EPS Diluted Growth -58.33 % 10.27 % 347.67 %
Book Value Per Share -44.97 % 11.76 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -48.52 % 53.21 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 860.1 % 167.88 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 860.1 % 1113.59 % 2268.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -4.33 % 0.06 % 95.27 %
Free Cash Flow Growth -100.14 % -0.08 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ABOS VRTX REGN VRNA ALNY ARGX
Gross Profit Margin TTM -1.69 % 86.28 % 85.39 % 95.15 % 83.99 % 65.82 %
Return on Assets TTM -93.76 % 14.78 % 11.4 % -11.01 % 0.9 % 15.06 %
Return on Equity TTM -97.41 % 21.81 % 15.31 % -30.05 % 26.13 % 18.96 %
Return on Capital Employed TTM -114.94 % 19.59 % 10.32 % -8.31 % 8.03 % 5.04 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % -136.38 % 237.3 %
EBT Per Ebit TTM 96.47 % 111.4 % 139.5 % 130.36 % -12.07 % 147.38 %
EBIT Per Revenue TTM -77657.3 % 34.06 % 25.89 % -25.86 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM -3436.83 % 202.64 % 187.43 % -29.66 % 9.59 % 932.29 %
Receivables Turnover TTM - 6.02 2.51 1.93 3.33 1.91
Payables Turnover TTM 0.27 0.4 2.3 2.37 4.37 0.9
Inventory Turnover TTM - 0.99 0.64 0.94 6.82 2.26
Fixed Asset Turnover TTM - 388.59 % 284.82 % 6536.22 % 463.12 % 5009.77 %
Asset Turnover TTM 0.13 % 47.15 % 35.47 % 29.27 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -2.04 14.55 48.94 -0.85 2.02 5.67
Free Cash Flow Per Share TTM -2.04 13.06 40.09 -0.85 1.68 5.58
Cash Per Share TTM 209.02 % 2459.7 % 8148.65 % 511.43 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -69470.22 % 31.71 % 35.59 % -43.23 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 89.76 % 81.92 % 100.75 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM -3436.83 % 202.64 % 187.43 % -29.66 % 9.59 % 932.29 %
Price To Free Cash Flows Ratio TTM -0.99 37.23 18.98 -995.27 252.16 127.91
Price To Operating Cash Flows Ratio TTM -0.99 33.28 15.6 -126.33 208.89 146.1
Price Cash Flow Ratio TTM -0.99 33.28 15.6 -126.33 208.89 146.1
Income Statement (TTM)
ABOS VRTX REGN VRNA ALNY ARGX
Revenue $0B $11.02B $14.2B $0.03B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $0.03B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 93.89% 85.62% 89.62%
EBITDA $-0.1B $0.49B $5.32B $-0.12B $-0.18B $0.11B
Net Income $-0.1B $-0.54B $4.41B $-0.14B $-0.28B $0.83B
EPS Diluted -1.71 -2.08 38.34 -1.73 -2.18 12.78
Balance Sheet (MRQ)
ABOS VRTX REGN VRNA ALNY ARGX
Long Term Debt $0.03B $1.66B $2.7B $0.12B $2.59B $0.03B
Total Liabilities $0.06B $6.12B $8.41B $0.27B $4.17B $0.7B
Total Equity $0.18B $16.41B $29.35B $0.2B $0.07B $5.5B
Total Investments $0.2B $6.65B $15.42B $0.02B $1.73B $1.93B
Total Debt $0.03B $1.75B $2.7B $0.12B $2.74B $0.04B
Total Assets $0.24B $22.53B $37.76B $0.47B $4.24B $6.2B
Cash Flow Statement (TTM)
ABOS VRTX REGN VRNA ALNY ARGX
Net Income $-0.1B $-0.54B $4.41B $-0.17B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.62B $-0.01B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.09B $-0.49B $4.42B $-0.12B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 27.89
AARD Aardvark Therapeutics, Inc. Common Stock 14.51
ABCL AbCellera Biologics Inc. 4.11
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.09
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.014
ABSI Absci Corporation 3.44
ABUS Arbutus Biopharma Corporation 4.65
ABVC ABVC BioPharma, Inc. 2.25
ABVX Abivax SA American Depositary Shares 115.49
ACAD ACADIA Pharmaceuticals Inc. 26.91
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 8.09
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 5.47
ACIU AC Immune SA 3.44
ACLX Arcellx, Inc. 64.31
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 258.27
VTI Vanguard Total Stock Market Index Fund 0.0001 340.14
IBB iShares Biotechnology ETF 0.01258 172.26
IWN iShares Russell 2000 Value ETF 0.00035 189.97
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 82.3548
VXF Vanguard Extended Market Index Fund 0.00072 217.2
HDG ProShares Hedge Replication ETF 0.000269689 52.1087
UWM ProShares Ultra Russell2000 0.00157102 51.67
VTHR Vanguard Russell 3000 Index Fund 0 304.79
IWC iShares Micro-Cap ETF 0.02 165.24
URTY ProShares UltraPro Russell2000 0.00125687 61.2
VTWV Vanguard Russell 2000 Value Index Fund 0.00373 167.45
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0.00168 104.4
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 49.01
VUN.TO Vanguard U.S. Total Market Index ETF 0.0001 128.18
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.0001 118.29
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 114.55
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00017 114.53
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00008 52.28
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00008 52.27
VBINX Vanguard Balanced Index Fund Investor Shares 0.00008 52.28
VGRO.TO Vanguard Growth ETF Portfolio 0.00004 43.85
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00005 55.13
VBAL.TO Vanguard Balanced ETF Portfolio 0.00003 37.46
VCNS.TO Vanguard Conservative ETF Portfolio 0.00002 31.82
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.1
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00001 26.7
BMED BlackRock Future Health ETF 0.03 31.03
DFAU Dimensional US Core Equity Market ETF 0.00048189 47.52
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 28.9033
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 62.18
DFAS Dimensional U.S. Small Cap ETF 0.0001142 72.84
DFAC Dimensional U.S. Core Equity 2 ETF 0.00004592 40.44
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 7.34
VTSAX Vanguard Total Stock Market Index Fund 0.0001 165.59
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 8.5425
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00072 164.85
VITSX Vanguard Total Stock Market Index Fund 0.0001 165.62
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 8.504
IBRN iShares Neuroscience and Healthcare ETF 0.17376 32.375
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 16.63
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00072 164.86
AVSC Avantis U.S. Small Cap Equity ETF 0 61.53
VTS.AX Vanguard US Total Market Shares Index ETF 0.0001 508.49
DCOR Dimensional ETF Trust 0.00005219 75.04
VEMPX Vanguard Extended Market Index InstlPlus 0.00072 406.81
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.0001 310.68
RSSL Global X Funds 0 101.24
DXUV Dimensional ETF Trust 0.0000186 61.44
Unlock